New Delhi, March 24 -- The national drug regulator on Tuesday intensified its vigil on the supply chain of GLP-1-based weight loss medications following reports of unauthorised sales and misuse. The move comes after the drug regulator conducted coordinated inspections at 49 different sites, including online pharmacies, wholesalers, and wellness clinics across the country.

The action aims to secure the supply chain and ensure these specialised drugs are not distributed through illegal channels.

Recently, the Central Drugs Standard Control Organisation (CDSCO) issued a strict advisory warning pharmaceutical companies against promoting prescription weight drugs to the general public. Doctors say this diktat must be followed by all.

On the...